title: A model for the mechanism of precise integration of a microinjected transgene.
abstract: A unique transgenic mouse line has undergone transgene integration in a very precise fashion. The phenotype displayed by mice of the line followed the predicted inheritance patterns for X-linked transgene insertion which has been confirmed. In order to investigate the mechanism of integration the DNA sequence of the transgene and cellular junctions have been determined. A comparison between wild type and transgenic mutant sequences at the site of insertion revealed that there was no loss or rearrangement of cellular DNA upon integration of the transgene. The cellular sequences at the transgene 5' and 3' joins are contiguous in the wild type. The integrant exists as a head to tail tandem dimer with minimal loss of sequence compared with the injected monomer. Analysis of the site of insertion has revealed a 5 bp homology between the 5' end of the transgene and the cellular sequences. In addition, adjacent to the site of insertion within the cellular sequences, there are several sequence motifs implicated in recombination events including a clustering of strong consensus sites of DNA topoisomerase type I and a region of homology to the human minisatellite consensus core sequence, the Escherichia coli Chi site and the meiotic recombination hotspot within the E beta gene of the murine major histocompatibility complex. This clustering of features is likely to have been factorial in the integrity of the insertion event. A model depicting the mechanism of this precise integration is proposed.
authors.affiliation: Robertson Laboratory of Biotechnology, Division of Molecular Genetics, University of Glasgow, UK.
authors.forename: M
authors.initials: M
authors.lastname: McFarlane
authors.forename: J B
authors.initials: JB
authors.lastname: Wilson
mesh_terms: D000818:Animals; D001483:Base Sequence; D002972:Cleft Palate / Q000235:genetics; D004247:DNA / Q000235:genetics; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D004274:DNA, Recombinant / Q000235:genetics; D004817:Epidermis / Q000473:pathology; D005260:Female; D005785:Gene Conversion; D005814:Genes, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics; D006801:Humans; D006965:Hyperplasia; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic / Q000235:genetics*; D008845:Microinjections; D008957:Models, Genetic; D008969:Molecular Sequence Data; D011120:Polyomavirus / Q000235:genetics; D011995:Recombination, Genetic; D012045:Regulatory Sequences, Nucleic Acid; D012689:Sequence Homology, Nucleic Acid; D019076:Transgenes; D014763:Viral Matrix Proteins / Q000096:biosynthesis / Q000235:genetics; D014960:X Chromosome / Q000235:genetics*
chemical_list: D004274:DNA, Recombinant; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D014763:Viral Matrix Proteins; D004247:DNA; D004264:DNA Topoisomerases, Type I